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with appropriate antibiotics. and cholecystectomy may be necessary 
if the gallbladder fails to reduce in size. 
PRIMARY SCLEROSING CHOLANGITIS 
Primary sclerosing cholangitis (PSC) is a chronic disorder of the 
larger bile ducts. It may involve any portion of the intrahepatic or 
extrahepatic biliary system and results in strictures. stone formation. 
tule stasis. and decreased liver synthetic function. Its etiology is un-
known. and there is a higher frequency of HLA DR3 and 88 in these 
patients than in healthy individuals. The characteristic lesion of PSC 
" flbroobliterative bile duct destruction. but this is present in only 
10% to 50% of patients undergoing liver biopsy. Thus. histologic 
diagnosis can be difficult. The primary role of liver biopsy. therefore. 
IS to both exclude other diseases and confirm that the pathologic 
changes present are consistent with PSC. Endoscopic retrograde chol-
angiopancreatography (ERCP) is a highly sensitive test for demon-
strating PSC. This disease occurs predominantly in males and is often 
associated with both ulcerative colitis and immunodeficiency states. 
It may be caused by an immune-mediated process. as portal infiltrates 
consist mainly of T cells. and there are circulating autoantibodies. of 
which those directed against neutrophils have sparked the most in-
terest. These perinuclear anuneutrophil cytoplasmic antibodies 
(pANCA) have been found also m a significant number of patients 
with ulcerative colitis. UDCA and immunosuppressive agents such 
,IS methotrexate are the principal agents used to achieve remission. 
Once complete obstruction occurs. therapeutic ERCP may permit 
dIlatation of stenotic areas of the affected bile ducts. With disease 
that progresses despite maximal medical therapy. patients become 
candidates for OLT. 
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Increasing numbers of hepatic mass lesions are found incidentally 
by advanced imaging technology. Although most of these incidental 
tumors are histologically benign and do not require any therapy. they 
must be thoroughly investigated. Modern imaging technology is quite 
efficient in detecting small lesions but is not effective in producing 
pathognomonic findings of many hepatic lesions other than heman-
giomas and cysts. Percutaneous needle biopsy often fails to establish 
a definitive diagnosis because of its limited sampling, and it can cause 
serious hemorrhage when unwisely performed for vascular lesions. 
Major hepatic resections can now be performed with minimum 
operative risk (less than 5%). but no surgeon should explore a hepatic 
mass without having the competence to perform all of the major 
resections. including a right and left trisegmentectomy. 
BENIGN TUMORS 
Most of the benign tumors of the liver are asymptomatic and are 
found inCidentally during studies for other disorders or during ab-
dominal operations. The general approach to a small incidental tumor 
(less than 3 cm in diameter) that is considered benign is close ob-
servation after thorough investigation. When the tumor changes its 
unaging characteristics or increases in size during close observation. 
U must be excised immediately. Larger incidental tumors. other than 
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asymptomatic cavernous hemangiomas. deserve excisional therapy 
unless unequivocal benignity is confirmed. 
Hemangiomas are the most common benign tumors of the liver. 
Giant cavernous hemangiomas should be treated by surgical excision. 
particularly when they are symptomatic (e.g .• pain. mass-related com-
plaints) or are found to have a necrotic center inside. The majority 
of giant cavernous hemangiomas require lobectomies or trisegmen-
tectomies of the liver. but some located on the surface of the liver or 
pedunculated can be enucleated along pseudocapsular margins without 
significant loss of normal liver tissue. Ligation or embolization of the 
feeding hepatic artery and radiation therapy may be hazardous and 
do not have long-standing effects on the course of giant cavernous 
hemangiomas. 
Infantile hemangioendotheliomas are seen most often in infants 
during the first 6 months of life and are distinct from cavernous 
hemangiomas. The lesions should be excised by anatomic hepatic 
resection whenever possible. Treatment with prednisone. diuretics. 
and digoxin can be used initially when the patient's condition prohibits 
surgery or the lesion is too extensive for resection. Response to pred-
nisone may allow surgery to be performed safely in a few weeks. In 
extensive lesions. radiation to the liver may be used after pathologic 
diagnosis is confirmed. Favorable responses to steroids. radiation. and 
hepatic artery ligation or embolization have been reported. The treat-
ment should be vigorous because complete regression and cure are 
possible. 
Other benign tumors include liver cell adenoma. focal nodular 
hyperplasia. hematoma. mesenchymoma. teratoma. and fibroma. Ra-
diologic differentiation of these benign tumors from malignant tumors 
is unreliable. Pathologic confirmation of benign tumors is mandatory 
for each lesion. Large benign tumors should be treated by surgical 
excision. particularly when they are symptomatic. Adenoma has a 
tendency to rupture and cause life-threatening hemorrhage. Some 
adenomas cannot be easily differentiated from low-grade hepatocel-
lular carcinoma by needle biopsies. If the diagnosis is uncertain. the 
lesion should be excised with an adequate margin without delay. 
Congenital hepatic cysts are usually asymptomatic and do not 
require any therapy. Although aspiration. internal drainage. marsu-
pialization. fenestration. and sclerotherapy have all been recom-
mended for symptomatic congenital cysts. these approaches are no 
longer justifiable for the treatment of single or localized multiple cysts 
because hepatic resections can be performed quite safely now. 
MALIGNANT TUMORS 
The most common primary malignant tumor of the liver in children 
is hepatoblastoma. Hepatocellular carcinoma is the second most com-
mon and usually occurs in older children. Sarcomas of the liver. such 
as rhabdomyosarcoma and angiosarcoma. are rare. None of these has 
a favorable outlook. but fibrolamellar hepatocellular carcinoma. which 
is common in older children and young adults. has a better prognosis 
than other types of malignancy. 
The treatment for all malignant liver tumors is complete surgical 
excision by anatomic hepatic resection. Hepatic resection of more 
than the right or left lobe of the liver can be performed quite safely. 
For example. a large tumor occupying the right lobe of the liver and 
the medial segment of the left lobe can be resected by right hepatic 
trisegmentectomy. leaving only the left lateral segment of the left lobe 
(to the left of the falciform ligament). or a large tumor occupying the 
left lobe and the anterior segment of the right lobe can be resected 
by left hepatic trisegmentectomy. leaving only the posterior segment 
of the right lobe (posterior to the right hepatic vein). These major 
hepatic resections can now be performed by experienced surgeons 
with less than a 5% operative mortality. 
We have found that computed tomography scan or magnetic res-
onance imaging is most useful in assessing the extent of the tumor. 
. but findings can be misleading, particularly when a large tumor distorts 
normal anatomic boundaries. If the resectability is uncertain after 
extensive preoperative investigation. the patient should be referred to 
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a sutgcOn who is experienced in major hepatic resection rather than 
undergo exploratory celiotomy by someone who is unprepared to_ 
undertake a definitive procedure. -
After curative hepatic resection, we usually recommend that pa-
tients receive adjuvant chemotherapy for at least I year. We have 
been using combination chemotherapy with doxorubicin, dactino-
mycin, vincristine, and cyclophosphamide. and often mitomycin or 
cisplatin. The value of this approacb bas not been validated in ran-
domized trials, but the patients who have received adjuvant chemo-
therapy after curative resections of large tumors have seemed to have 
longer tumor-free survival. 
In general. liver transplantation (total bepatectomy and liver re-
placement) cannot offer good long-term results when applied to large 
malignant tumors that cannot be removed by subtotal hepatectomy. 
However. liver transplantation can result in a cure (more than 5-year 
survival) on more than isolated occasions. The most favorable lesions 
for transplantation. just as with resection. are the fibrolamellar hep-
atoma and epithelioid hemagioendothelial sarcoma. On the other hand. 
most of the patients who have received liver transplantation for other 
end-stage liver diseases. such as tyrosinemia and alpha,-antitrypsin 
deficiency disease. and whose malignant tumors were small and in-
cidental survived tumor free for several years. 
The most common metastatic liver tumors in children are neuro-
blastoma and Wilms' tumor. Although chemotherapy and radiation 
therapy may be helpful in treating these metastatic tumors. the lesion 
should be excised whenever possible. particularly if it is localized to 
part of the liver. Hepatic resections for metastatic tumors are much 
safer than those for primary malignancy. 
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The clinical entity of intestinal failure includes an extremely varied 
array of causative diseases. associated anomalies. and complicating 
factors. with one common denominator: they all rely on total par-
enteral nutrition (TPN) for their survival. The introduction of TPN 
has improved the outcome of many patients and is the accepted ther-
apeutic modality today. However. some patients suffer complications 
of this therapy. principally liver dysfunction and venous access com-
plications. that limit its long-term use. Also. the frequent morbidity 
and need for specialized care and hospitalizations place a significant 
drain on the health care system_ Finally. the social awkwardness and 
emotional demands on the family can hinder tremendously the normal 
developmental and behavioral maturity of children. There is an urgent 
need for achieving success with intestinal transplantation. 
INDICATIONS 
The inability to maintain a normal nutritional status by the use of 
the gastrointestinal tract alone constitutes IOtestinai failure (IF) _ Chil-
dren with IF usually have had major bowel resections because of 
catastrophic gastrointestinal disease or suffer functional abnormalities 
as a result of motility or secretory I absorpuve disorders. 
The following are major indications for intestinal transplan-
tation In children: 
• Congenital malformations 
• Gastroschisis 
• Hirschsprung's disease 
• Necrotizing enterocolitis 
• Pseudoobstruction 
• Volvulus 
The composition of the allograft type focuses on the integrity of 
the remaining gut and other abdominal organs. Those patients with 
IF and cholestatic liver disease secondary to TPN are candidates for 
combined liver intestinal transplant (LlTX). Guidelines used in as-
sessing the need for a concomitant liver transplant include biochemical 
parameters, histology, and the presence of portal hypertension. Pa-
tients with functional disorders may require replacement of the entire 
gastrointestinal tract. Candidates for isolated intestinal transplant 
(1TX) are those who present incipient signs of TPN injury to the liver. 
although without significant damage, and those who have suffered 
multiple septic episodes from line infection. with consequent throm-
bosis, and are limited in the availability of access sites. These patients 
are in danger of progressively depleting these sites and should be 
considered for ITX.' 
A potential small bowel transplant recipient should have a thorough 
assessment of nutritional history and present nutritional status. as well 
as an outline of the abdominal anatomy. This should allow for planning 
of the optimum time for transplantation, as well as for accurate plan-
ning of graft type. 
THE OPERATION 
A history of normal intestinal function in a patient referred for 
potential liver donation is considered adequate for possible intestinal 
donation. The donor should be hemodynamically stable, without a 
need for vasopressor suppon. There should be no history of cardiac 
arrest. The adequacy of the intestine is assessed by the donor team 
at the time of surgery_ We select a donor of similar or smaller size 
than the recipient. The ABO blood groups should be identical. and 
there is no HLA matching. 
The procurement of mUltiple visceral organs (en-bloc or as separate 
components) focuses on the isolation and cooling of the organs. pre-
serving their vascular and parenchymal anatomy. The complete mul-
tivisceral retrieval includes the stomach. duodenum, pancreas. liver. 
and small and large intestine. After encirclement of the proximal aorta 
near the diaphragm and the distal aorta below the origin of the inferior 
mesenteric artery. the organs are flushed with chilled University of 
Wisconsin (UW) solution via a catheter inserted into the lower ab-
dominal aorta. In situations where the liver is not required in the graft. 
it may be separated in situ after perfusion or at the back table. Back 
table irrigation of the intestinal lumen is required only when the colon 
is included in the graft. Manipulation of the graft lymphoreticular 
tissue (using polyclonal or monoclonal antilymphocyte antibody prep-
arations or radiation) is not performed. 
The recipient operation focuses on preservation of the remaining 
bowel and the status of the native liver. The final judgment as to graft 
type is made at this time. The liver is usually excised. preserving the 
retrohepatic vena cava as for a piggyback transplant. A portacaval 
shunt is used when the liver is removed. and the proximal gut is 
preserved (stomach. duodenum. pancreas. spleen). thus allowing de-
compression of these organs. This is not required in recipients of a 
complete multivisceral transplant (MVTX) or ITX graft. 
Revascularization in the MVTX or LITX graft uses a Carrel patch 
containing the celiac and superior mesenteric arteries. which is anas-
tomosed to the recipient infrarenal aorta (with or without an inter-
position graft of donor thoracic or abdominal aorta). The venous 
drainage of the graft is into the hepatic veins of the recipient. After 
reperfusion. the portacaval shunt may be taken down. and a recipient 
portal vein-to-donor portal vein anastomosis may be performed. In 
the ITX graft. the superior mesenteric artery IS anastomosed into the 
infrarenal aorta. The venous drainage of this type graft can be into 
the native superior mesenteric vein. the portal vein at the level of the 
hepatic hilus. or the inferior vena cava. The graft is reperfused after 
unclamping of the arterial inflow. allowing bleeding to occur from 
the venous outflow anastomotic lines_ This allows for drainage of the 
potassium-rich UW solution. The venous drainage clamps are then 
removed. The gastrointestinal tract is reconstructed in a standard fash-
ion. anastomosing to native intestine proximally and distally. Biliary 
reconstruction is required only in reCipients of an LITX graft and is 
